Global Gaucher Disease Market 2015-2019

  • Published on
    30-Dec-2015

  • View
    42

  • Download
    1

Embed Size (px)

DESCRIPTION

Gaucher disease is a rare, inherited metabolic disorder caused by the deficiency of the enzyme glucocerebrosidase. This in turn causes the accumulation of certain detrimental lipids in the body, especially the glycolipid glucocerebroside. The lipids are accumulated mainly within the macrophages, blood cells, spleen, liver, and bone marrow. Approximately 34 genetic mutations have been identified that leads to Gaucher disease, out of which there are four most prominent mutations that lead to more than half of the Gaucher disease globally. Some people may have no symptoms of this disease, while some experience severe complications. Some of the clinical manifestations of this disease are hepatosplenomegaly, anemia, thrombocytopenia, and skeletal abnormalities. Get detailed information on: http://www.researchbeam.com/global-gaucher-disease-2015-2019-market - PowerPoint PPT Presentation

Transcript

Global Gaucher Disease Market 2015-2019 Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Forecast 2015- 2019

  • TELEPHONE: +1 (855) 711-1555E-MAIL: sales@researchbeam.com